Hikma Pharmaceuticals Plc Director/PDMR Shareholding (6780C)
April 18 2013 - 5:29AM
UK Regulatory
TIDMHIK
RNS Number : 6780C
Hikma Pharmaceuticals Plc
18 April 2013
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters
State whether the notification
relates to (i) a transaction
notified in accordance with
DTR 3.1.2 R, (ii) a disclosure
made in accordance with
LR 9.8.6R(1) or (iii) a
disclosure made in accordance
with section 793 of the
Name of the Issuer: Companies Act (2006):
1. Hikma Pharmaceuticals PLC 2. DTR 3.1.2 R
---- --------------------------------------- ---- -----------------------------------
Name of person discharging State whether notification
managerial responsibilities/director: relates to a person connected
Samih Darwazah, Said Darwazah, with a person discharging
Mazen Darwazah and Ali Al-Husry managerial responsibilities/
as directors of Hikma and director named in 3 and
non-executive directors identify the connected person:
3. of Darhold. 4. Yes: Darhold Limited
---- --------------------------------------- ---- -----------------------------------
Indicate whether the notification
is in respect of a holding
of the person referred to Description of shares (including
in 3 or 4 above or in respect class), debentures or derivatives
of a non-beneficial interest: or financial instruments
Beneficial interest Darhold relating to shares:
5. Limited 6. Ordinary Shares
---- --------------------------------------- ---- -----------------------------------
Name of registered shareholders(s)
and, if more than one, the State the nature of the
number of shares held by transaction:
each of them: Grant of a pledge over 3,800,000
Citigroup Global Markets Ordinary Shares in support
7. Limited 8. of a loan
---- --------------------------------------- ---- -----------------------------------
Percentage of issued class
acquired (treasury shares
Number of shares, debentures of that class should not
or financial instruments be taken into account when
relating to shares acquired: calculating percentage):
9. None 10. N/A
---- --------------------------------------- ---- -----------------------------------
Percentage of issued class
disposed (treasury shares
Number of shares, debentures of that class should not
or financial instruments be taken into account when
relating to shares disposed: calculating percentage):
11. None 12. N/A
---- --------------------------------------- ---- -----------------------------------
Price per share or value
of transaction: Date and place of transaction:
13. N/A 14. London, 16 April 2013
---- --------------------------------------- ---- -----------------------------------
Total holding following
notification and total percentage
holding following notification
(any treasury shares should
not be taken into account Date issuer informed of
when calculating percentage): transaction:
15. 57,183,028 - 28.96 per cent. 16. 17 April 2013
---- --------------------------------------- ---- -----------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer complete the following boxes
------------------------------------------------------------------------------
Period during which or date
17. Date of grant 18. on which exercisable
---- --------------------------------- ---- -------------------------------
Total amount paid (if Description of shares or
any) for grant of the debentures involved (class
19. option 20. and number)
---- --------------------------------- ---- -------------------------------
Exercise price (if fixed
at time of grant) or indication Total number of shares or
that price is to be fixed debentures over which options
21. at the time of exercise 22. held following notification
---- --------------------------------- ---- -------------------------------
Name of contact and telephone
23. Any additional information 24. number for queries
---- --------------------------------- ---- -------------------------------
Name of authorised official or issuer responsible for making
notification
Peter Speirs, Company Secretary, Hikma Pharmaceuticals PLC
Date of notification: 18 April 2013
-------------------------------------------------------------
Notes:
This form is intended for use by an issuer to make a RIS
notification required by DTR 3.1.4
(1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6,
8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options
granted to a director/person discharging managerial
responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a
debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16,
23 and 24.
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters
State whether the notification
relates to (i) a transaction
notified in accordance with
DTR 3.1.2 R, (ii) a disclosure
made in accordance with
LR 9.8.6R(1) or (iii) a
disclosure made in accordance
with section 793 of the
Name of the Issuer: Companies Act (2006):
25. Hikma Pharmaceuticals PLC 26. DTR 3.1.2 R
---- --------------------------------------- ---- -----------------------------------
Name of person discharging State whether notification
managerial responsibilities/director: relates to a person connected
Samih Darwazah, Said Darwazah, with a person discharging
Mazen Darwazah and Ali Al-Husry managerial responsibilities/
as directors of Hikma and director named in 3 and
non-executive directors identify the connected person:
27. of Darhold. 28. Yes: Darhold Limited
---- --------------------------------------- ---- -----------------------------------
Indicate whether the notification
is in respect of a holding
of the person referred to Description of shares (including
in 3 or 4 above or in respect class), debentures or derivatives
of a non-beneficial interest: or financial instruments
Beneficial interest Darhold relating to shares:
29. Limited 30. Ordinary Shares
---- --------------------------------------- ---- -----------------------------------
Name of registered shareholders(s)
and, if more than one, the State the nature of the
number of shares held by transaction:
each of them: Release of a pledge over
31. Jordan Kuwait Bank plc 32. 3,800,000 Ordinary Shares
---- --------------------------------------- ---- -----------------------------------
Percentage of issued class
acquired (treasury shares
Number of shares, debentures of that class should not
or financial instruments be taken into account when
relating to shares acquired: calculating percentage):
33. None 34. N/A
---- --------------------------------------- ---- -----------------------------------
Percentage of issued class
disposed (treasury shares
Number of shares, debentures of that class should not
or financial instruments be taken into account when
relating to shares disposed: calculating percentage):
35. None 36. N/A
---- --------------------------------------- ---- -----------------------------------
Price per share or value
of transaction: Date and place of transaction:
37. N/A 38. London, 16 April 2013
---- --------------------------------------- ---- -----------------------------------
Total holding following
notification and total percentage
holding following notification
(any treasury shares should
not be taken into account Date issuer informed of
when calculating percentage): transaction:
39. 57,183,028 - 28.96 per cent. 40. 17 April 2013
---- --------------------------------------- ---- -----------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer complete the following boxes
------------------------------------------------------------------------------
Period during which or date
41. Date of grant 42. on which exercisable
---- --------------------------------- ---- -------------------------------
Total amount paid (if Description of shares or
any) for grant of the debentures involved (class
43. option 44. and number)
---- --------------------------------- ---- -------------------------------
Exercise price (if fixed
at time of grant) or indication Total number of shares or
that price is to be fixed debentures over which options
45. at the time of exercise 46. held following notification
---- --------------------------------- ---- -------------------------------
Name of contact and telephone
47. Any additional information 48. number for queries
---- --------------------------------- ---- -------------------------------
Name of authorised official or issuer responsible for making
notification
Peter Speirs, Company Secretary, Hikma Pharmaceuticals PLC
Date of notification: 18 April 2013
-------------------------------------------------------------
Notes:
This form is intended for use by an issuer to make a RIS
notification required by DTR 3.1.4
(1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6,
8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options
granted to a director/person discharging managerial
responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a
debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16,
23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSGCGDSRDBBGXI
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
